Osaic Holdings
PHAT icon

Osaic Holdings’s Phathom Pharmaceuticals PHAT Stock Holding History

Osaic Holdings’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.6K Sell
2,304
-4,146
-64% -$52.4K ﹤0.01% 5705
2025
Q4 		$107K Sell
6,450
-4,502
-41% -$64.3K ﹤0.01% 4648
2025
Q3 		$130K Sell
10,952
-298
-3% -$3.08K ﹤0.01% 4570
2025
Q2 		$108K Hold
11,250
– – ﹤0.01% 4448
2025
Q1 		$70.5K Buy
11,250
+7,958
+242% +$48.3K ﹤0.01% 4452
2024
Q4 		$26.7K Buy
3,292
+2,277
+224% +$28.2K ﹤0.01% 5133
2024
Q3 		$18.4K Sell
1,015
-1,200
-54% -$16.8K ﹤0.01% 5436
2024
Q2 		$22.8K Buy
2,215
+1,985
+863% +$20.4K ﹤0.01% 5255
2024
Q1 		$2.44K Sell
230
-49
-18% -$416 ﹤0.01% 6393
2023
Q4 		$2.54K Sell
279
-2,434
-90% -$21K ﹤0.01% 6448
2023
Q3 		$28.1K Sell
2,713
-1,538
-36% -$21.1K ﹤0.01% 5368
2023
Q2 		$59.4K Buy
4,251
+4,100
+2,715% +$47.3K ﹤0.01% 4820
2023
Q1 		$1.08K Buy
151
+1
+0.7% +$9 ﹤0.01% 6928
2022
Q4 		$2K Sell
150
-400
-73% -$4.12K ﹤0.01% 6691
2022
Q3 		$6K Sell
550
-12,011
-96% -$114K ﹤0.01% 6289
2022
Q2 		$106K Sell
12,561
-35,854
-74% -$369K ﹤0.01% 4380
2022
Q1 		$659K Buy
48,415
+42,747
+754% +$691K ﹤0.01% 2958
2021
Q4 		$112K Buy
5,668
+3,592
+173% +$84.5K ﹤0.01% 4503
2021
Q3 		$67K Buy
2,076
+853
+70% +$28.3K ﹤0.01% 4879
2021
Q2 		$41K Hold
1,223
– – ﹤0.01% 5191
2021
Q1 		$46K Hold
1,223
– – ﹤0.01% 4937
2020
Q4 		$41K Hold
1,223
– – ﹤0.01% 4697
2020
Q3 		$45K Buy
1,223
+473
+63% +$16.4K ﹤0.01% 4376
2020
Q2 		$25K Buy
+750
New +$28.8K ﹤0.01% 4666

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Osaic Holdings's PHAT Position: Q1 2026 in Review

Osaic Holdings reduced its Phathom Pharmaceuticals (PHAT) stake by 64% in Q1 2026, selling an estimated $52.4K and leaving 2,304 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5705.

Osaic Holdings first reported a position in PHAT in Q2 2020 and has held it in 24 quarters since. The position peaked at $659K in Q1 2022. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

  • Osaic Holdings held 2,304 shares of Phathom Pharmaceuticals worth $25.6K as of Q1 2026.
  • Osaic Holdings sold 4,146 Phathom Pharmaceuticals shares in Q1 2026, an estimated $52.4K.
  • Phathom Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5705 holding.
  • Osaic Holdings first reported a position in Phathom Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Phathom Pharmaceuticals position peaked at $659K in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.